系列活检肾脏各分室的分子谱分析可区分狼疮性肾炎治疗应答者与无应答者
研究对58例狼疮性肾炎患者发作时首次活检(Bx1)和治疗后第二次活检(Bx2)的肾脏组织进行转录组分析,激光显微切割分离肾小球和肾小管间质,比较临床完全应答者、部分应答者和无应答者的基因表达。结果显示不同时间点肾小球和肾小管间质的特定基因群可区分无应答者与完全应答者,尿补体成分5a和纤连蛋白-1蛋白水平反映了发作时和治疗后的相应基因表达。
要点
- Bx1时肾小球整合素、中性粒细胞、趋化因子/细胞因子及肾小管间质趋化因子、T细胞和白细胞黏附基因可区分无应答者与完全应答者。
- Bx2时肾小球单核细胞、细胞外基质和干扰素及肾小管间质干扰素、补体和T细胞转录本可区分无应答者与完全应答者。
- 尿补体成分5a和纤连蛋白-1蛋白水平反映发作时和治疗后肾脏补体和纤连蛋白表达。
核心结论
- 系列狼疮性肾炎肾脏活检的转录分析显示,肾脏基因表达随临床治疗成功与否而变化。
- 对治疗应答和无应答分子景观的认识可能有助于使狼疮性肾炎管理与肾脏损伤发病机制相一致。
研究设计与样本
- 对58例狼疮性肾炎患者在发作时(首次活检Bx1)和治疗后(第二次活检Bx2)进行方案肾脏活检。
- 使用激光显微切割分离肾小球和肾小管间质,提取RNA并通过nanostring技术分析转录本表达。
- 比较临床完全应答者、部分应答者和无应答者在Bx1和Bx2时的转录表达,并与健康对照比较。
- 通过共聚焦显微镜和尿ELISA在蛋白水平验证区分临床完全应答者与无应答者的顶级转录本。
主要发现
- Bx1时聚类分析确定肾小球整合素、中性粒细胞、趋化因子/细胞因子和肾小管间质趋化因子、T细胞和白细胞黏附基因能够区分无应答者与临床完全应答者。
- Bx2时肾小球单核细胞、细胞外基质和干扰素,以及肾小管间质干扰素、补体和T细胞转录本区分无应答者与临床完全应答者。
- 蛋白分析鉴定出狼疮性肾炎发作时多个过表达的肾小球和肾小管间质转录本的蛋白产物,重现了顶级转录本发现。
- 尿补体成分5a和纤连蛋白-1蛋白水平反映发作时和治疗后的补体和纤连蛋白表达。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The immune pathways that define treatment response and non-response in lupus nephritis (LN) are unknown. To characterize these intra-kidney pathways, transcriptomic analysis was done on protocol kidney biopsies obtained at flare (initial biopsy (Bx1)) and after treatment (second biopsy (Bx2)) in 58 patients with LN. Glomeruli and tubulointerstitial compartments were isolated using laser microdissection. RNA was extracted and analyzed by nanostring technology with transcript expression from clinically complete responders, partial responders and non-responders compared at Bx1 and Bx2 and to the healthy controls. Top transcripts that differentiate clinically complete responders from non-responders were validated at the protein level by confocal microscopy and urine ELISA. At Bx1, cluster analysis determined that glomerular integrin, neutrophil, chemokines/cytokines and tubulointerstitial chemokines, T cell and leukocyte adhesion genes were able to differentiate non-responders from clinically complete responders. At Bx2, glomerular monocyte, extracellular matrix, and interferon, and tubulointerstitial interferon, complement, and T cell transcripts differentiated non-responders from clinically complete responders. Protein analysis identified several protein products of overexpressed glomerular and tubulointerstitial transcripts at LN flare, recapitulating top transcript findings. Urine complement component 5a and fibronectin-1 protein levels reflected complement and fibronectin expression at flare and after treatment. Thus, transcript analysis of serial LN kidney biopsies demonstrated how gene expression in the kidney changes with clinically successful and unsuccessful therapy. Hence, these insights into the molecular landscape of response and non-response may help align LN management with the pathogenesis of kidney injury.
引用
- Parikh SV, Malvar A, Song H, et al. Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis. Kidney Int. 2022. PMID: 35788359. doi:10.1016/j.kint.2022.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。